BlueWind Medical™ Ltd. Makes Key Additions to Leaders

PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ -- BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder, today announced

Related Keywords

United States , United Kingdom , Israel , Kellogg School , California , Boston , Massachusetts , Sweden , Herzliya , Tel Aviv , Ireland , Irvine , Utah , London , City Of , Americans , America , American , Sandra Muhlfeld , Ethicon Endosurgery , Mike Ruger , Lisa Mead , Dan Lemaitre , University Of California , Emerson University , Bluewind Medical Ltd , Drug Administration , American Urological Association , University Of Connecticut , National Health Service , Kellogg School Of Management At Northwestern University , Silara Medtech Inc , Relationship To Mental Health , Medtronic , University Of Northern Colorado , Bluewind Medical , Overactive Bladder , Vice President , Senior Sales , Executive Leadership , North America , Business Management , Caldera Medical , Physical Therapy , Human Resources , Direct Flow Medical , Silara Medtech , Urinary Urgency Incontinence , Wind Medical , Investigational Device Exemption , Urinary Incontinence , Mental Health , Health Related Quality , European Urology , Prnewswire , ,